EWM
SRNE

Edge Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Edge Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,300
Closed -$15K – 458
2015
Q1 		$15K Buy
+1,300
New +$15K 0.01% 276

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Edge Wealth Management's SRNE Position: Q2 2015 in Review

Edge Wealth Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2015, closing a stake of 1,300 shares — an estimated $15K sold.

Edge Wealth Management first reported a position in SRNE in Q1 2015 and held it in 1 quarter. The position peaked at $15K in Q1 2015. 75 funds tracked by Wall St. Rank hold SRNE as of Q2 2015.

  • Edge Wealth Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2015 after selling out during the quarter.
  • Edge Wealth Management sold 1,300 Sorrento Therapeutics, Inc. shares in Q2 2015, an estimated $15K.
  • Edge Wealth Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2015 and held it in 1 quarter.
  • Edge Wealth Management's Sorrento Therapeutics, Inc. position peaked at $15K in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2015.

Based on Edge Wealth Management's 13F filing for Q2 2015, filed 7 Jul 2015.